CD302 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.906200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.089200E-01
Normal-vs-Stage2
5.946800E-01
Normal-vs-Stage3
2.037800E-01
Normal-vs-Stage4
6.065800E-01
Stage1-vs-Stage2
7.517200E-01
Stage1-vs-Stage3
4.035800E-01
Stage1-vs-Stage4
4.190400E-01
Stage2-vs-Stage3
4.597200E-01
Stage2-vs-Stage4
1.540590E-01
Stage3-vs-Stage4
1.130050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.321000E-01
Normal-vs-AfricanAmerican
7.869000E-01
Normal-vs-Asian
2.150800E-01
Caucasian-vs-AfricanAmerican
4.195200E-01
Caucasian-vs-Asian
1.933350E-01
AfricanAmerican-vs-Asian
2.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.963800E-01
Normal-vs-Female
7.110400E-01
Male-vs-Female
3.350800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.851400E-01
Normal-vs-Age(41-60Yrs)
9.188000E-01
Normal-vs-Age(61-80Yrs)
4.834200E-01
Normal-vs-Age(81-100Yrs)
6.231600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.860000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.748200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.598200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.170300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.582900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.456100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.846400E-01
Normal-vs-Daily Drinker
4.688000E-02
Normal-vs-Weekly Drinker
5.892200E-01
Normal-vs-Occasional Drinker
2.364400E-01
Normal-vs-Social Drinker
9.424400E-01
Non Drinker-vs-Daily Drinker
3.338800E-01
Non Drinker-vs-Weekly Drinker
4.083800E-01
Non Drinker-vs-Occasional Drinker
9.327600E-01
Non Drinker-vs-Social Drinker
2.204000E-01
Daily Drinker-vs-Weekly Drinker
1.256770E-01
Daily Drinker-vs-Occasional Drinker
2.648600E-01
Daily Drinker-vs-Social Drinker
8.175600E-02
Weekly Drinker-vs-Occasional Drinker
4.530000E-01
Weekly Drinker-vs-Social Drinker
5.623800E-01
Occasional Drinker-vs-Social Drinker
2.414800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.668200E-01
Normal-vs-Grade 2
2.548200E-01
Normal-vs-Grade 3
2.553800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.316400E-01
Grade 1-vs-Grade 3
8.062000E-01
Grade 1-vs-Grade 4
3.668200E-01
Grade 2-vs-Grade 3
1.911040E-01
Grade 2-vs-Grade 4
2.548200E-01
Grade 3-vs-Grade 4
2.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.748200E-01
Normal-vs-NonDiabetic
4.353800E-01
Diabetic-vs-NonDiabetic
7.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.189390E-01
Normal-vs-NoPancreatitis
5.008800E-01
Pancreatitis-vs-NoPancreatitis
3.141600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.914600E-01
Normal-vs-N1
6.135600E-01
N0-vs-N1
7.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.117810E-01
Normal-vs-TP53-NonMutant
9.022800E-01
TP53-Mutant-vs-TP53-NonMutant
5.593500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
